HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Israel Vlodavsky Selected Research

heparitinsulfate lyase

9/2007The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
5/2007Heparanase enhances syndecan-1 shedding: a novel mechanism for stimulation of tumor growth and metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Israel Vlodavsky Research Topics

Disease

166Neoplasms (Cancer)
01/2022 - 01/2002
111Neoplasm Metastasis (Metastasis)
01/2022 - 04/2002
64Inflammation (Inflammations)
01/2022 - 09/2002
28Carcinoma (Carcinomatosis)
01/2021 - 06/2006
22Breast Neoplasms (Breast Cancer)
10/2019 - 12/2003
16Carcinogenesis
01/2021 - 12/2003
10Melanoma (Melanoma, Malignant)
01/2020 - 08/2004
9Lymphoma (Lymphomas)
01/2019 - 07/2002
8Fibrosis (Cirrhosis)
01/2022 - 05/2004
8Glioma (Gliomas)
01/2019 - 10/2003
7Alzheimer Disease (Alzheimer's Disease)
10/2021 - 05/2005
7Hyperglycemia
01/2018 - 11/2002
6Infections
12/2021 - 04/2004
6Pathologic Processes
12/2021 - 06/2003
6Graft vs Host Disease (Graft-Versus-Host Disease)
12/2021 - 03/2010
6Diabetic Nephropathies (Diabetic Nephropathy)
06/2021 - 11/2002
6Sarcoma (Soft Tissue Sarcoma)
05/2019 - 09/2011
6Leukemia
06/2018 - 01/2002
5Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2005
5Colitis
06/2021 - 01/2007
5Hematologic Neoplasms (Hematological Malignancy)
05/2019 - 12/2009
5Atherosclerosis
06/2013 - 01/2004
4Virus Diseases (Viral Diseases)
12/2021 - 12/2020
4Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 12/2006
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 08/2004
4Disease Progression
11/2020 - 02/2015
4Brain Neoplasms (Brain Tumor)
01/2017 - 09/2004
4Hypoxia (Hypoxemia)
01/2016 - 10/2005
3Pancreatitis
06/2021 - 01/2017
3Colonic Neoplasms (Colon Cancer)
01/2020 - 10/2004
3Malignant Mesothelioma
12/2018 - 01/2004
3Proteinuria
04/2016 - 01/2012
3Albuminuria
04/2016 - 01/2012
3Diabetes Mellitus
01/2016 - 05/2013
3Vascular System Injuries
06/2013 - 01/2002
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2012 - 01/2007
3Choriocarcinoma
05/2010 - 10/2003
3Hyperplasia
05/2008 - 01/2002
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 05/2004
2Necrosis
01/2022 - 07/2008
2COVID-19
06/2021 - 11/2020
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2021 - 07/2008
2Stomach Neoplasms (Stomach Cancer)
01/2021 - 01/2021
2Multiple Myeloma
01/2020 - 03/2011

Drug/Important Bio-Agent (IBA)

209heparanaseIBA
01/2022 - 01/2002
64Heparitin Sulfate (Heparan Sulfate)IBA
01/2022 - 05/2002
42EnzymesIBA
10/2021 - 07/2002
31Glycoside Hydrolases (Endoglycosidases)IBA
01/2022 - 01/2004
24Heparin (Liquaemin)FDA LinkGeneric
06/2021 - 01/2002
20Proteins (Proteins, Gene)FDA Link
04/2021 - 01/2002
20GlucuronidaseIBA
01/2021 - 07/2002
18Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2022 - 11/2002
14Pharmaceutical PreparationsIBA
01/2021 - 01/2006
12Biological ProductsIBA
11/2020 - 01/2004
10Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2020 - 01/2004
9CytokinesIBA
01/2021 - 07/2008
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2018 - 02/2006
8Proteoglycans (Proteoglycan)IBA
06/2021 - 10/2010
8Messenger RNA (mRNA)IBA
12/2011 - 03/2002
7Amyloid (Amyloid Fibrils)IBA
10/2021 - 05/2005
6Peptides (Polypeptides)IBA
04/2021 - 08/2006
6Syndecan-1 (Syndecan 1)IBA
12/2020 - 05/2007
6Monoclonal AntibodiesIBA
01/2019 - 06/2006
5Small Interfering RNA (siRNA)IBA
01/2020 - 08/2004
5Polysaccharides (Glycans)IBA
01/2019 - 05/2005
5AnticoagulantsIBA
04/2015 - 01/2003
4Insulin (Novolin)FDA Link
01/2022 - 01/2017
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
11/2020 - 01/2007
4SST 0001IBA
01/2016 - 03/2011
4SelectinsIBA
05/2011 - 07/2007
3Blood Glucose (Blood Sugar)IBA
01/2022 - 02/2011
3Neutralizing AntibodiesIBA
06/2021 - 01/2011
3Interleukin-6 (Interleukin 6)IBA
11/2020 - 01/2017
3OligosaccharidesIBA
01/2020 - 08/2012
3Estrogens (Estrogen)FDA Link
10/2019 - 12/2003
3P-SelectinIBA
01/2019 - 05/2011
3ChemokinesIBA
01/2019 - 09/2010
3LipopolysaccharidesIBA
01/2019 - 10/2012
3ErbB Receptors (EGF Receptor)IBA
01/2018 - 12/2008
3Sulfates (Sulfates, Inorganic)IBA
01/2017 - 04/2005
3Vascular Endothelial Growth Factor CIBA
10/2016 - 12/2008
3CollagenIBA
04/2016 - 11/2012
3Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2016 - 05/2013
3AntigensIBA
08/2012 - 08/2006
3Matrix Metalloproteinases (MMPs)IBA
06/2011 - 01/2009
3Cell Adhesion MoleculesIBA
05/2011 - 06/2003
3Estrogen ReceptorsIBA
11/2009 - 12/2003
3Thromboplastin (Tissue Factor)IBA
03/2008 - 01/2007
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2007 - 01/2004
32-(4-hydroxyphenoxy)acetic acid-formaldehyde polymerIBA
01/2003 - 01/2002
2Proteasome Endopeptidase Complex (Proteasome)IBA
04/2021 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
03/2021 - 12/2013
2Phosphotransferases (Kinase)IBA
01/2021 - 12/2016
2CeruletideIBA
01/2021 - 01/2017
2Acetates (Acetic Acid Esters)FDA Link
01/2021 - 08/2014
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 04/2018
2Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 10/2016

Therapy/Procedure

28Therapeutics
01/2022 - 04/2005
9Drug Therapy (Chemotherapy)
01/2020 - 04/2005
3Transplantation
01/2021 - 03/2008